Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses (Q36198462)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

quantitative structure-activity relationship

1 reference

based on heuristic

inferred from title

object named as

Abdo A Elfiky

1

0 references

author name string

Samah M Mahdy

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Wael M Elshemey

3

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

publication date

19 November 2016

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1040-1047

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Coronaviruses - drug discovery and therapeutic options.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Pathogenesis of Middle East respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Emergence of MERS-CoV in the Middle East: origins, transmission, treatment, and perspectives

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Evidence supporting a zoonotic origin of human coronavirus strain NL63

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Evidence for an Ancestral Association of Human Coronavirus 229E with Bats

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Evidence for zoonotic origins of Middle East respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Mechanisms of coronavirus cell entry mediated by the viral spike protein

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

A previously undescribed coronavirus associated with respiratory disease in humans

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Coronaviruses: important emerging human pathogens

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Evidence for camel-to-human transmission of MERS coronavirus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

SARS--beginning to understand a new virus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Human aminopeptidase N is a receptor for human coronavirus 229E

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Anti-HCV drugs in the pipeline

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Molecular modeling comparison of the performance of NS5b polymerase inhibitor (PSI-7977) on prevalent HCV genotypes

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Daclatasvir plus sofosbuvir for HCV infection: an oral combination therapy with high antiviral efficacy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Integrative computational modeling of protein interactions

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

2′-Methylguanosine Prodrug (IDX-184), Phosphoramidate Prodrug (Sofosbuvir), Diisobutyryl Prodrug (R7128) Are Better Than Their Parent Nucleotides and Ribavirin in Hepatitis C Virus Inhibition: A Molecular Modeling Study

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Structural properties of metal-free apometallothioneins

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

The EBI Search engine: providing search and retrieval functionality for biological data from EMBL-EBI

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Deciphering key features in protein structures with the new ENDscript server

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

The I-TASSER Suite: protein structure and function prediction.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Verification of protein structures: patterns of nonbonded atomic interactions

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Deviations from standard atomic volumes as a quality measure for protein crystal structures

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): structural evidence for nucleotide import and de-novo initiation

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Water Determines the Structure and Dynamics of Proteins

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Safety and pharmacokinetics of IDX184, a liver-targeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FJMV.24736

21 January 2018

The QSAR and docking calculations of fullerene derivatives as HIV-1 protease inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27864902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/JMV.24736

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36198462&oldid=1961621795"